Applied Therapeutics Ownership | Who Owns Applied Therapeutics?

Applied Therapeutics Ownership Summary

Applied Therapeutics is owned by 82.37% institutional investors, 5.24% insiders, and 12.39% retail investors. Franklin resources is the largest institutional shareholder, holding 8.15% of APLT shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 3.75% of its assets in Applied Therapeutics shares.

APLT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Applied Therapeutics	82.37%	5.24%	12.39%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Franklin resources	10.21M	8.15%	$47.69M
Vr adviser	9.54M	7.61%	$44.57M
Janus henderson group	7.65M	6.10%	$35.49M
Blackrock	6.57M	5.24%	$30.68M
Propel bio management	6.57M	5.24%	$30.67M
Knoll capital management	5.57M	4.45%	$26.03M
Vestal point capital, lp	5.43M	4.33%	$25.36M
Vanguard group	5.32M	4.25%	$24.86M
Morgan stanley	3.52M	2.81%	$16.44M
Simplify asset management	2.82M	2.25%	$13.16M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Propel bio management	6.57M	19.89%	$30.67M
Knoll capital management	5.57M	17.54%	$26.03M
Stempoint capital lp	2.21M	3.03%	$10.33M
Vr adviser	9.54M	2.84%	$44.57M
Vestal point capital, lp	5.43M	1.89%	$25.36M
Opaleye management	1.68M	1.79%	$7.85M
Tang capital management	2.33M	1.11%	$10.88M
Simplify asset management	2.82M	0.88%	$13.16M
Parkman healthcare partners	1.15M	0.72%	$5.36M
Soleus capital management	1.27M	0.52%	$5.93M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	6.57M	0.00%	5.58M
Vanguard group	5.32M	0.00%	2.31M
Deutsche bank ag\	2.34M	0.00%	1.72M
Geode capital management	2.10M	0.00%	1.49M
State street	1.66M	0.00%	1.45M

Top Sellers

Holder	Shares	% Assets	Change
Alyeska investment group	-	-	-4.00M
Frazier life sciences management	-	-	-2.29M
Laurion capital management lp	50.00K	0.00%	-1.43M
Schonfeld strategic advisors	533.73K	0.02%	-1.30M
Millennium management	110.91K	0.00%	-815.52K

New Positions

Holder	Shares	% Assets	Change	Value
Peregrine capital management	731.05K	0.10%	731.05K	$3.41M
Nuveen asset management	271.61K	0.00%	271.61K	$1.27M
Hennion & walsh asset management	197.04K	0.05%	197.04K	$920.19K
Sei investments	114.62K	0.00%	114.62K	$535.27K
Alps advisors	89.13K	0.00%	89.13K	$416.24K

Sold Out

Holder	Change
Newedge advisors	-199.00
Tower research capital llc (trc)	-10.26K
Ctc alternative strategies	-10.40K
Raymond james & associates	-10.66K
Gsa capital partners llp	-10.92K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	101	1.00%	103,226,978	9.86%	82	1.47%	62	-7.46%	24	50.00%
Mar 31, 2024	100	12.36%	93,965,703	53.04%	74	1.41%	67	15.52%	16	45.45%
Dec 31, 2023	89	56.14%	61,400,847	42.94%	72	3.25%	58	70.59%	11	57.14%
Sep 30, 2023	57	32.56%	42,956,878	36.52%	47	2.99%	34	70.00%	7	-22.22%
Jun 30, 2023	43	22.86%	31,465,662	63.23%	39	3.40%	20	25.00%	9	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Franklin Biotechnology Discv A(acc)USD	4.31M	3.75%	-1.29M
Vanguard Total Stock Mkt Idx Inv	3.16M	2.71%	4.60K
Simplify Propel Opportunities ETF	2.82M	2.42%	-
Franklin Biotechnology Discovery A	2.49M	2.17%	-717.00K
iShares Russell 2000 ETF	2.49M	2.14%	-5.59K
SPDR® S&P Biotech ETF	1.76M	1.53%	19.44K
Vanguard Institutional Extnd Mkt Idx Tr	1.15M	1.00%	-298.33K
Fidelity Small Cap Index	984.01K	0.86%	-25.59K
Janus Henderson Hrzn Biotec E2 USD	762.22K	0.66%	202.19K
Xtrackers S&P 500 Swap ETF 1C	622.23K	0.53%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 22, 2024	Funtleyder Leslie D.	Chief Financial Officer	Sell	$78.88K
Aug 22, 2024	Perfetti Riccardo	Chief Medical Officer	Sell	$132.23K
Aug 13, 2024	Shendelman Shoshana	President and CEO	Sell	$2.21M
Aug 14, 2024	Shendelman Shoshana	President and CEO	Sell	$709.17K
Aug 12, 2024	Shendelman Shoshana	President and CEO	Sell	$1.79M

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	5
2024 Q2	-	5
2024 Q1	-	4
2023 Q4	1	7
2023 Q3	-	3

APLT Ownership FAQ

Who Owns Applied Therapeutics?

Applied Therapeutics shareholders are primarily institutional investors at 82.37%, followed by 5.24% insiders and 12.39% retail investors. The average institutional ownership in Applied Therapeutics's industry, Biotech Stocks , is 44.97%, which Applied Therapeutics exceeds.

Who owns the most shares of Applied Therapeutics?

Applied Therapeutics’s largest shareholders are Franklin resources (10.21M shares, 8.15%), Vr adviser (9.54M shares, 7.61%), and Janus henderson group (7.65M shares, 6.10%). Together, they hold 21.87% of Applied Therapeutics’s total shares outstanding.

Does Blackrock own Applied Therapeutics?

Yes, BlackRock owns 5.24% of Applied Therapeutics, totaling 6.57M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.68M$. In the last quarter, BlackRock increased its holdings by 5.58M shares, a 564.10% change.

Who is Applied Therapeutics’s biggest shareholder by percentage of total assets invested?

Propel bio management is Applied Therapeutics’s biggest shareholder by percentage of total assets invested, with 19.89% of its assets in 6.57M Applied Therapeutics shares, valued at 30.67M$.

Who is the top mutual fund holder of Applied Therapeutics shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of Applied Therapeutics shares, with 3.75% of its total shares outstanding invested in 4.31M Applied Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools